Repozytorium

Strategies for overcoming tropical disease by ruthenium complexes with purine analog : application against Leishmania spp. and Trypanosoma cruzi.

Autorzy

Marzena Fandzloch

José Manuel Méndez Arriaga

Manuel Sánchez-Moreno

Andrzej Wojtczak

Julia Jezierska

Jerzy Sitkowski

Joanna Wiśniewska

Juan Manuel Salas

Iwona Łakomska

Rok wydania

2017

Czasopismo

Journal of Inorganic Biochemistry

Numer woluminu

176

Strony

144-155

DOI

10.1016/j.jinorgbio.2017.08.018

Kolekcja

Naukowa

Język

Angielski

Typ publikacji

Artykuł

Streszczenie

Tropical diseases currently constitute a major health problem and thus a challenge in the field of drug discovery. The current treatments show serious disadvantages due to cost, toxicity, long therapy duration and resistance, and the use of metal complexes as chemotherapeutic agents against these ailments appears to be a very attractive alternative. Herein, we describe three newly synthesized ruthenium complexes with a bioactive molecule, the purine analogue 5,6,7-trimethyl-1,2,4-triazolo[1,5-a]pyrimidine (tmtp): cis,fac-[RuCl2(dmso)3(tmtp)] (1), mer-[RuCl3(dmso)(H2O)(tmtp)]·2H2O (2) and fac,cis-[RuCl3(H2O)(tmtp)2] (3). Their structures were characterized using X-ray and spectroscopic methods (IR, NMR or EPR). The stability of the synthesized complexes 13 in various buffered solutions (pH = 3–7.4) was monitored using conventional and stopped-flow techniques. The in vitro antiproliferative activity of all ruthenium complexes against promastigote forms of Leishmania spp. (L. infantumL. braziliensis, and L. donovani) and epimastigote forms of Trypanosoma cruzi was investigated. Notably, the results showed that the activity of 1 against L. brasiliensis was more than three-fold higher than that of glucantime, and 1 showed no appreciable toxicity towards J774.2 macrophages. Additionally, 2 displayed even 141-fold lower toxicity against host cells than glucantime, demonstrating significantly higher selectivity than the reference drug. Therefore, 1 and 2 appear to be excellent candidates for further development as potential drugs for the effective treatment of leishmaniasis and Chagas disease. All novel complexes were also shown to be potent inhibitors of Fe-SOD in the studied species, while their effects on human CuZn-SOD were very low.

Adres publiczny

https://doi.org/10.1016/j.jinorgbio.2017.08.018

Strona internetowa wydawcy

http://www.elsevier.com